國際轉譯科學博士學位學程

Medicine & Life Sciences

1. 4-acetylantroquinonol B 14%
2. Adenocarcinoma 14%
3. Adenocarcinoma of Lung 15%
4. Androgen Receptors 19%
5. antrocin 33%
6. Antrodia 35%
7. Apoptosis 29%
8. Autophagy 13%
9. Biomarkers 26%
10. Bone Neoplasms 13%
11. Breast Neoplasms 42%
12. Carcinogenesis 49%
13. Carcinoma 13%
14. Castration 17%
15. Catenins 50%
16. Cell Line 23%
17. Cell Survival 14%
18. Chemoradiotherapy 26%
19. Cisplatin 13%
20. Cohort Studies 22%
21. Colon 15%
22. Colonic Neoplasms 23%
23. Colorectal Neoplasms 58%
24. Computational Biology 20%
25. Computer Simulation 21%
26. Confidence Intervals 22%
27. destruxin B 21%
28. DNA Repair 13%
29. Down-Regulation 39%
30. Drug Resistance 19%
31. Endometriosis 13%
32. Endothelial Cells 24%
33. Epithelial-Mesenchymal Transition 35%
34. ErbB Receptors 21%
35. Exosomes 16%
36. Extracellular Vesicles 14%
37. Galectin 1 19%
38. Gene Expression 17%
39. Genes 41%
40. Genome-Wide Association Study 18%
41. Glioblastoma 35%
42. Glioma 14%
43. Glycosylation 15%
44. Growth 36%
45. Haptoglobins 24%
46. Hepatocellular Carcinoma 37%
47. Hereditary Nonpolyposis Colorectal Neoplasms 17%
48. Heterografts 18%
49. Histone Deacetylase Inhibitors 33%
50. Histone Deacetylases 26%
51. Homeostasis 16%
52. HSP90 Heat-Shock Proteins 12%
53. Hypoxia-Inducible Factor 1 13%
54. Immunoglobulin G 13%
55. In Vitro Techniques 33%
56. Inflammation 16%
57. Inhibitory Concentration 50 33%
58. Lung Neoplasms 49%
59. Macrophages 13%
60. Mass Spectrometry 15%
61. Mesenchymal Stem Cells 26%
62. Metalloproteases 13%
63. MicroRNAs 50%
64. Mucuna 17%
65. Neoplasm Metastasis 50%
66. Neoplasms 100%
67. Neoplastic Stem Cells 59%
68. Neuropilin-1 14%
69. Non-Small Cell Lung Carcinoma 28%
70. ovatodiolide 48%
71. Pancreatic Neoplasms 13%
72. Pharmaceutical Preparations 26%
73. Phenotype 24%
74. Phosphorylation 15%
75. Population 22%
76. Prostatic Neoplasms 56%
77. Protein Isoforms 15%
78. Proteins 54%
79. pterostilbene 21%
80. Radiotherapy 13%
81. Recurrence 15%
82. Serum 15%
83. Single Nucleotide Polymorphism 14%
84. Smoking 16%
85. Sorafenib 15%
86. Squamous Cell Carcinoma 25%
87. Squamous Cell Carcinoma of Head and Neck 19%
88. Stem Cells 33%
89. Sumoylation 23%
90. Survival 22%
91. Taiwan 44%
92. Theranostic Nanomedicine 14%
93. Therapeutics 43%
94. TOR Serine-Threonine Kinases 16%
95. Triple Negative Breast Neoplasms 13%
96. Tumor Microenvironment 42%
97. Up-Regulation 25%
98. Uracil-DNA Glycosidase 16%
99. Vibrio parahaemolyticus 14%
100. White spot syndrome virus 1 15%

Chemical Compounds

1. 5-Fluorouracil 6%
2. 50 Percent Growth Inhibition 7%
3. Acetylation 5%
4. Adipogenic 5%
5. Adrenergic Alpha-1 Receptor Antagonist 6%
6. Amentoflavone 5%
7. Amino-Acid Residue 6%
8. Androgen 10%
9. Angiogenic 9%
10. Antagonist 9%
11. Anthocyanin 6%
12. Antiapoptotic 13%
13. Antigen 6%
14. Antiinflammatory 9%
15. Antineoplastic Agent 9%
16. Antioxidant Agent 7%
17. Antiproliferative 16%
18. Antitumor 6%
19. Antiviral Drug 5%
20. Antroquinonol 6%
21. Application 11%
22. Benzamide 7%
23. Biological Marker 16%
24. Cell Death 11%
25. Chemosensitizer 5%
26. Chidamide 11%
27. Cisplatin 6%
28. Colistin 5%
29. Colistin A 6%
30. Colistin B 6%
31. Compound Z 5%
32. Contrast Medium 5%
33. Disorder 6%
34. Drug 32%
35. Drug Target 8%
36. Fibrinolytic Agent 5%
37. Flavonoid 7%
38. Flow 8%
39. Food 5%
40. Gamma-Mangostin 6%
41. Garcinol 6%
42. Gemcitabine 10%
43. Glycopeptide 6%
44. Glycosylation 7%
45. Gonadotropin Releasing Hormone Agonist 6%
46. Growth Factor 10%
47. Growth Inhibition 7%
48. Heat 5%
49. Hispidulin 10%
50. Histone 24%
51. Hydroxamic Acid 9%
52. Iron Oxide 5%
53. Kd 6%
54. Lethal 9%
55. Liquid 7%
56. Luteolin 6%
57. Magnolol 10%
58. Marker 30%
59. Mass Spectrometry 6%
60. Memantine 5%
61. Metabolic 17%
62. MicroRNA 23%
63. Modification 6%
64. Molecule 11%
65. Mutation 6%
66. Nanomaterial 6%
67. Nanoparticle 11%
68. Neurotrophic Factor 5%
69. Niclosamide 11%
70. Oncogenic 22%
71. Oxidative Stress 5%
72. P62 5%
73. Paclitaxel 5%
74. Peptide 6%
75. Permeability 5%
76. Pharmacological Metabolism 9%
77. Phosphotransferase Inhibitor 5%
78. Plasma 19%
79. Poly(ADPribose) 6%
80. Protein 61%
81. Protodioscin 6%
82. Pterostilbene 11%
83. Purification 5%
84. Reactive Oxygen Metabolite 10%
85. Resistance 17%
86. Sample Preparation 6%
87. Shear Stress 6%
88. Simulation 7%
89. Small Interfering RNA 9%
90. Sorafenib 6%
91. Strain 7%
92. Sulforaphane 5%
93. Surface 6%
94. Thymosin Beta-4 6%
95. Toxin 6%
96. Tyrosine 8%
97. Volume 5%
98. White 5%
99. Zanamivir 5%